This inventor holds 2 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignees: Icahn School of Medicine at Mount Sinai, The United States Government as Represented by the Department of Veterans Affairs. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:


Years Active: 2026
Title: Richard T. Beresis: Inventor in Biomedical Research
Introduction
Richard T. Beresis is an inventor associated with San Francisco, California. His patent work includes research into compounds that may help address fibrotic diseases, including kidney fibrosis. The available information lists 2 patents.
Latest Patents
One of Beresis’s listed patents is titled “Oxygen-Containing Heterocyclic Compound and Use Thereof.” It describes oxadiazolyl dihydropyrano[2,3-b]pyridine compounds that inhibit HIPK2 and are proposed for treating kidney fibrosis.
The disclosed compounds selectively inhibit Smad3 activation. They are described as (3-aryl-1,2,4-oxadiazol-5-yl)-3,4-dihydro-2H-pyrano[2,3-b]pyridines, with an aryl or heteroaryl group. The patent presents these compounds as potential treatments for fibrotic diseases, particularly renal fibrosis, and other conditions associated with dysregulation of the HIPK2/Smad3 signaling pathway.
Career Highlights
Beresis is associated with the Icahn School of Medicine at Mount Sinai and the United States Department of Veterans Affairs. These affiliations connect his patent activity with biomedical research and the development of potential therapeutic approaches.
Collaborations
His listed coworkers include John Cijiang He and Kyung Lee. Their names appear alongside Beresis’s research and patent-related work.
Conclusion
Richard T. Beresis’s patent work focuses on compounds targeting the HIPK2/Smad3 pathway, with potential applications in treating kidney fibrosis and related fibrotic diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile